116 related articles for article (PubMed ID: 29346498)
21. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
[TBL] [Abstract][Full Text] [Related]
22. [Association over time of Hodgkin lymphoma and non-Hodgkin lymphoma: study of 6 patients in one single center].
Pérez-Montaña A; Sancho JM; Mate JL; Ribera JM
Med Clin (Barc); 2012 Dec; 139(15):695-6. PubMed ID: 22809967
[No Abstract] [Full Text] [Related]
23. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
[TBL] [Abstract][Full Text] [Related]
24. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique.
Tinger A; Wasserman TH; Klein EE; Miller EA; Roberts T; Piephoff JV; Kucik NA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):865-70. PubMed ID: 9128963
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database.
Kuo JH; Chabot JA; Lee JA
Surgery; 2016 Jan; 159(1):23-9. PubMed ID: 26522696
[TBL] [Abstract][Full Text] [Related]
26. [Second cancers after treatment of Hodgkin's disease: experience at the International Database on Hodgkin's disease (IDHD)].
Henry-Amar M
Bull Cancer; 1992; 79(4):389-91. PubMed ID: 1421702
[No Abstract] [Full Text] [Related]
27. Second malignant neoplasms following treatment for primary cancer.
Somerville HM
Aust Fam Physician; 2003; 32(1-2):25-31. PubMed ID: 12647655
[TBL] [Abstract][Full Text] [Related]
28. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
29. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
30. Incidence of malignant pleural mesothelioma after thoracic radiotherapy.
Neugut AI; Ahsan H; Antman KH
Cancer; 1997 Sep; 80(5):948-50. PubMed ID: 9307196
[TBL] [Abstract][Full Text] [Related]
31. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
32. Second malignancies in survivors of chronic myelomonocytic leukemia: a U.S. population-based study.
El-Fattah MA
Leuk Lymphoma; 2017 Sep; 58(9):1-7. PubMed ID: 28092999
[No Abstract] [Full Text] [Related]
33. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
Chang ET; Lau EC; Mowat FS; Teta MJ
Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
[TBL] [Abstract][Full Text] [Related]
35. Summaries for patients. Breast cancer in women who survived childhood cancer.
Ann Intern Med; 2004 Oct; 141(8):I30. PubMed ID: 15492332
[No Abstract] [Full Text] [Related]
36. Primary lymph node sites in Hodgkin lymphoma and the risk of second primary cancers: a population-based study.
Ebied A; Yousif M; Nam NH; Elhamamsy AR; Hassan OG; Mostafa EM; Nguyen GJ; Hirayama K; Huy NT
Future Oncol; 2020 Mar; 16(9):451-467. PubMed ID: 32096658
[No Abstract] [Full Text] [Related]
37. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract][Full Text] [Related]
38. Second cancer risk for Hodgkin's lymphoma survivors.
Baker H
Lancet Oncol; 2016 Feb; 17(2):e50. PubMed ID: 26774794
[No Abstract] [Full Text] [Related]
39. Second cancer among long-term survivors from Hodgkin's disease.
Nyandoto P; Muhonen T; Joensuu H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):373-8. PubMed ID: 9788418
[TBL] [Abstract][Full Text] [Related]
40. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
